Seeking Alpha

Valeant Pharmaceuticals (VRX) says that COO Rajiv De Silva will be leaving the company to pursue...

Valeant Pharmaceuticals (VRX) says that COO Rajiv De Silva will be leaving the company to pursue other interests. Mr. De Silva will remain with the company through the remainder of the year, once the integration of its recent acquisition of Medicis (MRX) is completed.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)